Acrivon Therapeutics, Inc. Banner Image

Acrivon Therapeutics, Inc.

  • Ticker ACRV
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Acrivon Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Cambridge, Massachusetts
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform. Their method is widely applicable across drug classes and modalities. We specifically apply their approach to challenging oncology drug targets causally implicated in the vast majority of cancers, particularly those without simple single geneMore driver mutations or synthetic lethal contexts. Leveraging their unique patient selection platform, Acrivon Therapeutics aims to rapidly progress in-licensed clinical-stage assets and a pipeline of internally developed programs through accelerated registration trials. Acrivon Therapeutics and its clinical biomarker development group is headquartered in the greater Boston area, with biomarker discovery efforts concentrated in their wholly-owned subsidiary in Lund, Sweden.
Acrivon Therapeutics, Inc.

Most Recent Annual Report

Acrivon Therapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K
Acrivon Therapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!